Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
41.28
+1.28 (3.20%)
Jan 21, 2025, 4:00 PM EST - Market closed
Ultragenyx Pharmaceutical Analyst Ratings
Total Analysts
15
Consensus Rating
Strong Buy
Price Target
$92.00
Upside
+122.87%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $135 → $140 | Buy | Maintains | $135 → $140 | +239.15% | Jan 13, 2025 |
| Wedbush | Wedbush | Hold Reiterates $46 → $48 | Hold | Reiterates | $46 → $48 | +16.28% | Jan 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $95 | Strong Buy | Reiterates | $95 | +130.14% | Dec 24, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $75 → $88 | Buy | Maintains | $75 → $88 | +113.18% | Dec 20, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $105 → $102 | Buy | Maintains | $105 → $102 | +147.09% | Nov 21, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $121 | Strong Buy | Maintains | $121 | +193.12% | Nov 12, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $109 → $121 | Strong Buy | Maintains | $109 → $121 | +193.12% | Nov 6, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $77 | Buy | Reiterates | $77 | +86.53% | Nov 6, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $116 | Buy | Reiterates | $116 | +181.01% | Nov 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $82 → $95 | Strong Buy | Maintains | $82 → $95 | +130.14% | Nov 6, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $116 | Buy | Reiterates | $116 | +181.01% | Oct 22, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $61 → $73 | Strong Buy | Maintains | $61 → $73 | +76.84% | Oct 21, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $116 | Buy | Reiterates | $116 | +181.01% | Oct 1, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $77 | Buy | Reiterates | $77 | +86.53% | Sep 26, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $116 | Buy | Reiterates | $116 | +181.01% | Sep 20, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $116 | Buy | Reiterates | $116 | +181.01% | Sep 16, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.